MEBUF(MEBUF)
MEBUF
Q4 2026 EPS Estimate
$0.19
Nov 6, 2026
Revenue Estimate
$371M
FY2027E EPS$124.18
FY2028E EPS$141.95
No analyst ratings available
No analyst price targets available for MEBUF
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+16.65%
EPS+42.78%
FY2028
Rev+17.10%
EPS+14.30%
FY2029
Rev+45.01%
EPS+7.36%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $257.42B | $301.44B | $437.12B | $264.11B |
| Low | $251.99B | $289.42B | $427.90B | $258.54B |
| High | $262.84B | $313.45B | $446.33B | $269.68B |
| EBITDA Avg | $9.36B | $9.58B | $10.51B | $9.93B |
| Low | $9.33B | $9.55B | $10.47B | $9.90B |
| High | $9.39B | $9.61B | $10.54B | $9.96B |
| EBIT Avg | $1.05B | $1.20B | $1.28B | $1.03B |
| Low | $1.02B | $1.16B | $1.25B | $1.01B |
| High | $1.08B | $1.23B | $1.32B | $1.06B |
| Net Income Avg | $739M | $845M | $907M | $730M |
| Low | $719M | $822M | $882M | $710M |
| High | $760M | $868M | $932M | $750M |
| EPS Avg | $124.18 | $141.95 | $152.40 | $122.64 |
| Low | $120.78 | $138.06 | $148.22 | $119.28 |
| High | $127.59 | $145.84 | $156.57 | $126.01 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $59.70B | $134.18B | $138.69B |
| Low | $59.70B | $134.18B | $138.69B |
| High | $59.70B | $134.18B | $138.69B |
| EBITDA Avg | $713M | $921M | $1.07B |
| Low | $713M | $921M | $1.07B |
| High | $713M | $921M | $1.07B |
| EBIT Avg | $250M | $288M | $271M |
| Low | $250M | $288M | $271M |
| High | $250M | $288M | $271M |
| Net Income Avg | $177M | $203M | $191M |
| Low | $177M | $203M | $191M |
| High | $177M | $203M | $191M |
| EPS Avg | $30.60 | $35.21 | $33.15 |
| Low | $30.60 | $35.21 | $33.15 |
| High | $30.60 | $35.21 | $33.15 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions
